Diagnostic yield of next‐generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta‐analysis. (5th January 2022)

• Record Type: Journal Article
• Authors: Pauta, M.; Martinez‐Portilla, R. J.; Borrell, A.
• Is Part Of: Ultrasound in obstetrics & gynecology. Volume 59:Number 1(2022)
• Page Start: 26
• Page End: 32
• Publication Date: 2022-01-05
• Subjects: diagnostic yield -- exome sequencing -- nuchal translucency -- prenatal diagnosis; Ultrasonics in obstetrics -- Periodicals; Generative organs, Female -- Diseases -- Diagnosis -- Periodicals; Diagnosis, Ultrasonic -- Periodicals; Genital Diseases, Female -- ultrasonography -- Periodicals; Ultrasonography, Prenatal -- Periodicals; 618.047543
• DOI: 10.1002/uog.23746
• Languages: English
• ISSNs: 0960-7692

Abstract

ABSTRACT: Objective: To determine the diagnostic yield of exome or genome sequencing (ES/GS) over chromosomal microarray analysis (CMA) in fetuses with increased nuchal translucency (NT) and no concomitant anomalies. Methods: This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses criteria. PubMed, Scopus and Web of Science were searched for studies describing ES/GS in fetuses with isolated increased NT. Inclusion criteria were: (1) study written in English; (2) more than two fetuses with increased NT > 99 th percentile and no concomitant anomalies; and (3) a negative CMA result considered as the reference standard. Only positive variants identified on ES/GS that were classified as likely pathogenic or pathogenic and determined to be causative of the fetal phenotype were considered. Risk was assessed as the pooled effect size by single‐proportion analysis using random‐effects modeling (weighted by inverse of variance). Results: Eleven studies reporting on the diagnostic yield of ES/GS in fetuses with isolated increased NT > 99 th percentile were identified and included 309 cases. All studies were high quality according to Standards for Reporting of Diagnostic Accuracy. Overall, a pathogenic or likely pathogenic variant was identified on ES/GS in 15 fetuses, resulting in a pooled incremental yield of 4% (95% CI, 2–6%). Six (40%) of these fetuses had NT of 5 mm or more. The observed inheritance pattern was autosomal dominant in 12 cases, including four fetuses with Noonan syndrome, autosomal recessive in two cases and X‐linked in one case. Conclusions: There is a 4% incremental diagnostic yield of ES/GS over CMA in fetuses with increased NT > 99 th percentile without a concomitant anomaly. It is unclear whether a NT cut‐off higher than 3.5 mm may be more useful in case selection for ES/GS. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.